UK-based Inflexion Private Equity (“Inflexion”), a mid-market private equity fund with a portfolio of more than 70 operating companies around the world, has bought Pharmaspectra LLC, which provides scientific knowledge services for the medical and pharmaceutical industry.
Inflexion is pleased to announce that it has agreed to acquire Pharmaspectra, a leading global provider of medical affairs data to the pharmaceutical and biotech industry. The investment is being made by Inflexion Enterprise Fund IV, Inflexion’s dedicated lower mid‐market fund.
L&L Partners advised
Update 25 March 2020: Economic Laws Practice (ELP) advised
2019-10-07
Deal value: Confidential
Primary jurisdiction of deal:
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.